Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2018 third-quarter earnings
FINAL LEDE- What You Need to Know About Johnson & Johnson's 2018 Third-Quarter Earnings- stock illustration graphic

What you need to know about Johnson & Johnson’s 2018 third-quarter earnings

Learn how the company’s consumer, pharmaceutical and medical devices businesses performed in the third quarter of 2018 in this snapshot of its latest earnings report.

Johnson & Johnson shared financial information this morning about its third-quarter performance in 2018.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

For more details about the company’s third-quarter 2018 results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.


3q2018-jj-earnings-infographic-web-final3.jpg

Johnson & Johnson’s 2018 3rd-Quarter Earnings

Read the earnings press release, which includes full financial data for the third quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson quarterly and full-year results here.

More from Johnson & Johnson

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.